These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2329562)

  • 21. Design, synthesis, and calcium channel antagonist activity of new 1,4-dihydropyridines containing 4-(5)-chloro-2-ethyl-5-(4)-imidazolyl substituent.
    Davood A; Mansouri N; Rerza Dehpour A; Shafaroudi H; Alipour E; Shafiee A
    Arch Pharm (Weinheim); 2006 Jun; 339(6):299-304. PubMed ID: 16649160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and calcium antagonistic activity of a new class of 1,4-dihydropyridines having an alkoxyimino group in position 3.
    Favara D; Nicola M; Pappalardo M; Bonardi G; Luca C; Marchini F; Sardi B
    Farmaco Sci; 1987 Oct; 42(10):697-708. PubMed ID: 3436440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-acting dihydropyridine calcium antagonists. 4. Synthesis and structure-activity relationships for a series of basic and nonbasic derivatives of 2-[(2-aminoethoxy)methyl]-1,4-dihydropyridine calcium antagonists.
    Alker D; Campbell SF; Cross PE; Burges RA; Carter AJ; Gardiner DG
    J Med Chem; 1990 Feb; 33(2):585-91. PubMed ID: 2153819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on dihydropyridines. III. Synthesis of 4,7-dihydrothieno [2,3-b]-pyridines with vasodilator and antihypertensive activities.
    Adachi I; Yamamori T; Hiramatsu Y; Sakai K; Mihara S; Kawakami M; Masui M; Uno O; Ueda M
    Chem Pharm Bull (Tokyo); 1988 Nov; 36(11):4389-402. PubMed ID: 3246006
    [No Abstract]   [Full Text] [Related]  

  • 25. Synthesis and antihypertensive activities of new 1,4-dihydropyridine derivatives containing nitrooxyalkylester moieties at the 3- and 5-positions.
    Ogawa T; Nakazato A; Tsuchida K; Hatayama K
    Chem Pharm Bull (Tokyo); 1993 Jun; 41(6):1049-54. PubMed ID: 8370105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis of asymmetric 4-aryl-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylates with vasodilating and antihypertensive activities.
    Ohno S; Komatsu O; Mizukoshi K; Ichihara K; Nakamura Y; Morishima T; Sumita K
    Chem Pharm Bull (Tokyo); 1986 Apr; 34(4):1589-606. PubMed ID: 3719860
    [No Abstract]   [Full Text] [Related]  

  • 27. Synthesis and cardiovascular properties of furazanyl-1,4-dihydropyridines and of furoxanyl analogues.
    Gasco AM; Fruttero R; Sorba G; Gasco A; Budriesi R; Chiarini A
    Arzneimittelforschung; 1992 Jul; 42(7):921-5. PubMed ID: 1418057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design of an antithrombotic-antihypertensive agent (Wy 27569). Synthesis and evaluation of a series of 2-heteroaryl-substituted dihydropyridines.
    Archibald JL; Bradley G; Opalko A; Ward TJ; White JC; Ennis C; Shepperson NB
    J Med Chem; 1990 Feb; 33(2):646-52. PubMed ID: 2299629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calcium channel blocking and positive inotropic activities of ethyl 5-cyano-1,4-dihydro-6-methyl-2-[(phenylsulfonyl)methyl]-4-aryl-3- pyridine-carboxylate and analogues. Synthesis and structure-activity relationships.
    Sircar I; Gregor EK; Anderson KR; Haleen SJ; Shih YH; Weishaar RE; Steffen RP; Pugsley TA; Taylor MD
    J Med Chem; 1991 Jul; 34(7):2248-60. PubMed ID: 2066997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design and synthesis of new 1,4-dihydropyridines containing 4(5)-chloro-5(4)-imidazolyl substituent as a novel calcium channel blocker.
    Iman M; Davood A; Nematollahi AR; Dehpoor AR; Shafiee A
    Arch Pharm Res; 2011 Sep; 34(9):1417-26. PubMed ID: 21975802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antihypertensive dihydropyridines with 1,4,4-trisubstitution.
    Kukla MJ; Breslin HJ; Gill A
    J Med Chem; 1990 Jan; 33(1):223-8. PubMed ID: 2296021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Active conformation of 1,4-dihydropyridine calcium entry blockers. Effect of size of 2-aryl substituent on rotameric equilibria and receptor binding.
    Rovnyak G; Andersen N; Gougoutas J; Hedberg A; Kimball SD; Malley M; Moreland S; Porubcan M; Pudzianowski A
    J Med Chem; 1991 Aug; 34(8):2521-4. PubMed ID: 1652021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative QSAR studies of two series of 1,4-dihydropyridines as slow calcium channel blockers.
    Wikel JH; Bemis KG; Kurz K; Denney ML; Main BW; Moore RA; Smith T; Shingleton L; Holland DR
    Drug Des Discov; 1994 Jan; 11(1):1-14. PubMed ID: 8068815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-acting dihydropyridine calcium antagonists. 1. 2-Alkoxymethyl derivatives incorporating basic substituents.
    Arrowsmith JE; Campbell SF; Cross PE; Stubbs JK; Burges RA; Gardiner DG; Blackburn KJ
    J Med Chem; 1986 Sep; 29(9):1696-702. PubMed ID: 2943898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis, structure, and pharmacological evaluation of the stereoisomers of furnidipine.
    Alajarin R; Vaquero JJ; Alvarez-Builla J; Pastor M; Sunkel C; Fau de Casa-Juana M; Priego J; Statkow PR; Sanz-Aparicio J; Fonseca I
    J Med Chem; 1995 Jul; 38(15):2830-41. PubMed ID: 7636844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of 3-[(2,3-dihydro-1,1,3-trioxo-1,2-benzisothiazol-2-yl)alkyl] 1,4-dihydropyridine-3,5-dicarboxylate derivatives as calcium channel modulators.
    Sunkel CE; Fau de Casa-Juana M; Santos L; García AG; Artalejo CR; Villarroya M; González-Morales MA; López MG; Cillero J; Alonso S
    J Med Chem; 1992 Jun; 35(13):2407-14. PubMed ID: 1377748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel 2-amino-1,4-dihydropyridine calcium antagonists. II. Synthesis and antihypertensive effects of 2-amino-1,4-dihydropyridine derivatives having N,N-dialkylaminoalkoxycarbonyl groups at 3- and/or 5-position.
    Kobayashi T; Inoue T; Nishino S; Fujihara Y; Oizumi K; Kimura T
    Chem Pharm Bull (Tokyo); 1995 May; 43(5):797-817. PubMed ID: 7553967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on nilvadipine. I. Synthesis and structure-activity relationships of 1,4-dihydropyridines containing novel substituents at the 2-position.
    Satoh Y; Ichihashi M; Okumura K
    Chem Pharm Bull (Tokyo); 1991 Dec; 39(12):3189-201. PubMed ID: 1814611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel 2-amino-1,4-dihydropyridine calcium antagonists. I. Synthesis and antihypertensive effects of 2-amino-1,4-dihydropyridine derivatives having nitroxy-alkoxycarbonyl groups at 3- and/or 5-position.
    Kobayashi T; Inoue T; Kita Z; Yoshiya H; Nishino S; Oizumi K; Kimura T
    Chem Pharm Bull (Tokyo); 1995 May; 43(5):788-96. PubMed ID: 7553966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative structure-activity relationships for 1,4-dihydropyridine calcium channel antagonists (nifedipine analogues): a quantum chemical/classical approach.
    Gaudio AC; Korolkovas A; Takahata Y
    J Pharm Sci; 1994 Aug; 83(8):1110-5. PubMed ID: 7983594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.